» Articles » PMID: 35102280

The Role of ROS in Tumour Development and Progression

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2022 Feb 1
PMID 35102280
Authors
Affiliations
Soon will be listed here.
Abstract

Eukaryotic cells have developed complex systems to regulate the production and response to reactive oxygen species (ROS). Different ROS control diverse aspects of cell behaviour from signalling to death, and deregulation of ROS production and ROS limitation pathways are common features of cancer cells. ROS also function to modulate the tumour environment, affecting the various stromal cells that provide metabolic support, a blood supply and immune responses to the tumour. Although it is clear that ROS play important roles during tumorigenesis, it has been difficult to reliably predict the effect of ROS modulating therapies. We now understand that the responses to ROS are highly complex and dependent on multiple factors, including the types, levels, localization and persistence of ROS, as well as the origin, environment and stage of the tumours themselves. This increasing understanding of the complexity of ROS in malignancies will be key to unlocking the potential of ROS-targeting therapies for cancer treatment.

Citing Articles

Impact of celastrol on mitochondrial dynamics and proliferation in glioblastoma.

Liang L, Lv W, Cheng G, Gao M, Sun J, Liu N BMC Cancer. 2025; 25(1):412.

PMID: 40050778 PMC: 11887396. DOI: 10.1186/s12885-025-13733-9.


The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.

Wang J, Shao F, Yu Q, Ye L, Wusiman D, Wu R Research (Wash D C). 2025; 8:0612.

PMID: 40046513 PMC: 11880593. DOI: 10.34133/research.0612.


Oxidative Stress and Reprogramming of Lipid Metabolism in Cancers.

Li S, Yuan H, Li L, Li Q, Lin P, Li K Antioxidants (Basel). 2025; 14(2).

PMID: 40002387 PMC: 11851681. DOI: 10.3390/antiox14020201.


Discovery and Characterization of a Distinctive Theaflavin-3-Gallate Isomer from with Potent Anticancer Properties Against Human Colorectal Carcinoma Cells.

Zhou L, Gao X, Huang Q, Chen Z, Zhang Y, Zhu F Foods. 2025; 14(4).

PMID: 40002048 PMC: 11854890. DOI: 10.3390/foods14040604.


Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy.

Khan T, Nagarajan M, Kang I, Wu C, Wangpaichitr M J Pers Med. 2025; 15(2).

PMID: 39997327 PMC: 11856717. DOI: 10.3390/jpm15020050.


References
1.
Holmstrom K, Finkel T . Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014; 15(6):411-21. DOI: 10.1038/nrm3801. View

2.
DAutreaux B, Toledano M . ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007; 8(10):813-24. DOI: 10.1038/nrm2256. View

3.
Winterbourn C . Hydrogen peroxide reactivity and specificity in thiol-based cell signalling. Biochem Soc Trans. 2020; 48(3):745-754. DOI: 10.1042/BST20190049. View

4.
Kong H, Chandel N . Regulation of redox balance in cancer and T cells. J Biol Chem. 2017; 293(20):7499-7507. PMC: 5961053. DOI: 10.1074/jbc.TM117.000257. View

5.
Poyton R, Ball K, Castello P . Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab. 2009; 20(7):332-40. DOI: 10.1016/j.tem.2009.04.001. View